HomeCompareEESO vs PFE

EESO vs PFE: Dividend Comparison 2026

EESO yields 10000000.00% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EESO wins by $4.762052817831319e+46M in total portfolio value
10 years
EESO
EESO
● Live price
10000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.762052817831319e+46M
Annual income
$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00
Full EESO calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — EESO vs PFE

📍 EESO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEESOPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EESO + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EESO pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EESO
Annual income on $10K today (after 15% tax)
$850,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, EESO beats the other by $40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EESO + PFE for your $10,000?

EESO: 50%PFE: 50%
100% PFE50/50100% EESO
Portfolio after 10yr
$2.3810264089156593e+46M
Annual income
$23,809,795,714,437,028,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

EESO
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EESO buys
0
PFE buys
0
No recent congressional trades found for EESO or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEESOPFE
Forward yield10000000.00%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.762052817831319e+46M$51.1K
Annual income after 10y$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00$27,210.54
Total dividends collected$4.762046689458665e+46M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EESO vs PFE ($10,000, DRIP)

YearEESO PortfolioEESO Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$1,000,010,700$1,000,000,000.00$9,161$701.38+$1000.00MEESO
2$93,460,013,936,683$93,458,943,925,233.62$8,610$859.79+$93460013.93MEESO
3$8,163,259,573,940,183,000$8,163,159,571,725,270,000.00$8,366$1,081.25+$8163259573940.17MEESO
4$666,373,880,559,373,300,000,000$666,365,145,871,629,100,000,000.00$8,483$1,405.66+$666373880559373312.00MEESO
5$50,838,057,311,279,720,000,000,000,000$50,837,344,291,227,520,000,000,000,000.00$9,084$1,907.24+$5.083805731127972e+22MEESO
6$3,624,737,622,195,432,400,000,000,000,000,000$3,624,683,225,474,109,500,000,000,000,000,000.00$10,418$2,732.78+$3.6247376221954326e+27MEESO
7$241,535,451,261,763,920,000,000,000,000,000,000,000$241,531,572,792,508,160,000,000,000,000,000,000,000.00$13,007$4,193.56+$2.4153545126176394e+32MEESO
8$15,041,872,435,857,020,000,000,000,000,000,000,000,000,000$15,041,613,992,924,168,000,000,000,000,000,000,000,000,000.00$18,010$7,005.87+$1.504187243585702e+37MEESO
9$875,466,765,540,973,800,000,000,000,000,000,000,000,000,000,000$875,450,670,737,467,500,000,000,000,000,000,000,000,000,000,000.00$28,216$12,979.89+$8.754667655409739e+41MEESO
10$47,620,528,178,313,184,000,000,000,000,000,000,000,000,000,000,000,000$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00$51,081$27,210.54+$4.762052817831319e+46MEESO

EESO vs PFE: Complete Analysis 2026

EESOStock

Enzyme Environmental Solutions, Inc. produces and sells industrial and agricultural enzyme products primarily in the United States. The company's enzyme products include cleaners, carpet shampoo cleaners, fabric prewash treatment, fleet and vehicle wash, glass and SS cleaners, bio gest, pit liquefiers, grease busters, industrial cleaners, laundry detergents, and mold and mildew cleaners. It also provides odor eliminators, rinse free floor cleaners, septic tank cleaners, tile and bath cleaners, toilet bowl cleaners, upholstery cleaners, vomit and odor remediation kits, and whirlpool and spa green clean systems. In addition, the company offers enzyme solutions to eliminate odor and organic matter, including blood stains; to clean carpets and counter tops; remove wall papers; and as a cleaner/degreaser. Its products are used in various industries, such as cleaning, health, and manufacturing, as well as for use as dietary supplements for humans and animals. The company was formerly known as Cucos Inc. and changed its name to Enzyme Environmental Solutions, Inc. in March 2008. Enzyme Environmental Solutions, Inc. was incorporated in 1981 and is based in Chicago, Illinois.

Full EESO Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this EESO vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EESO vs SCHDEESO vs JEPIEESO vs OEESO vs KOEESO vs MAINEESO vs JNJEESO vs MRKEESO vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.